Published in Nat Rev Immunol on June 01, 2005
Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol (2010) 3.15
The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 2.85
The burgeoning family of unconventional T cells. Nat Immunol (2015) 2.70
Deciphering and reversing tumor immune suppression. Immunity (2013) 2.24
MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci U S A (2009) 1.81
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med (2006) 1.79
Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun (2012) 1.69
The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc Natl Acad Sci U S A (2008) 1.54
Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res (2010) 1.25
Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling. J Biol Chem (2011) 1.21
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes. Proc Natl Acad Sci U S A (2011) 1.17
Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS One (2012) 1.16
Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol (2012) 1.14
Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens (2008) 1.13
Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine. Clin Vaccine Immunol (2010) 1.10
Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (2014) 1.07
Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells. Neoplasia (2011) 1.06
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects. J Exp Med (2009) 1.05
Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin Immunol (2011) 1.05
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors. J Biomed Biotechnol (2010) 1.05
High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J Transl Med (2011) 1.04
Comprehensive analysis of MHC class I genes from the U-, S-, and Z-lineages in Atlantic salmon. BMC Genomics (2010) 1.03
TL and CD8αα: Enigmatic partners in mucosal immunity. Immunol Lett (2010) 1.01
Molecular characterization of the immune system: emergence of proteins, processes, and domains. Immunogenetics (2007) 1.01
Nonconventional CD8+ T cell responses to Listeria infection in mice lacking MHC class Ia and H2-M3. J Immunol (2010) 1.00
Remarkable conservation of distinct nonclassical MHC class I lineages in divergent amphibian species. J Immunol (2010) 1.00
Unraveling the evolution of the Atlantic cod's (Gadus morhua L.) alternative immune strategy. PLoS One (2013) 0.98
Patterns of genetic differentiation at MHC class I genes and microsatellites identify conservation units in the giant panda. BMC Evol Biol (2013) 0.98
Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells. Proc Natl Acad Sci U S A (2009) 0.97
Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells. Proc Natl Acad Sci U S A (2011) 0.95
An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med (2008) 0.94
Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance. EMBO Rep (2007) 0.93
Macrophages express multiple ligands for gammadelta TCRs. Mol Immunol (2008) 0.92
The immunogenetics of Behçet's disease: A comprehensive review. J Autoimmun (2015) 0.91
SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors. Front Immunol (2014) 0.91
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens. Cancer Immunol Immunother (2011) 0.89
Roles for major histocompatibility complex glycosylation in immune function. Semin Immunopathol (2012) 0.88
Characterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas. J Immunol (2008) 0.87
Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors. Annu Rev Immunol (2015) 0.87
The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties. PLoS One (2011) 0.86
NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. PLoS Genet (2015) 0.86
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool. Immunol Rev (2015) 0.86
Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation. Am J Physiol Gastrointest Liver Physiol (2008) 0.86
A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS One (2010) 0.86
Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity. Curr Opin Immunol (2010) 0.86
Cutting edge: innate memory CD8+ T cells are distinct from homeostatic expanded CD8+ T cells and rapidly respond to primary antigenic stimuli. J Immunol (2013) 0.85
HLA-E expression in cervical adenocarcinomas: association with improved long-term survival. J Transl Med (2012) 0.85
Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome. Front Immunol (2014) 0.85
Self/nonself perception, reproduction and the extended MHC. Self Nonself (2010) 0.84
Defining the turkey MHC: identification of expressed class I- and class IIB-like genes independent of the MHC-B. Immunogenetics (2011) 0.83
Multiple divergent haplotypes express completely distinct sets of class I MHC genes in zebrafish. Immunogenetics (2013) 0.83
Unusual evolutionary conservation and further species-specific adaptations of a large family of nonclassical MHC class Ib genes across different degrees of genome ploidy in the amphibian subfamily Xenopodinae. Immunogenetics (2014) 0.83
Gammadelta T lymphocyte homeostasis is negatively regulated by beta2-microglobulin. J Immunol (2009) 0.82
Characterization and locus-specific typing of MHC class I genes in the red-billed gull (Larus scopulinus) provides evidence for major, minor, and nonclassical loci. Immunogenetics (2011) 0.82
Molecular characterization of major histocompatibility complex class I genes from the giant panda (Ailuropoda melanoleuca). Immunogenetics (2008) 0.82
A novel approach to analyze gene expression data demonstrates that the DeltaF508 mutation in CFTR downregulates the antigen presentation pathway. Am J Physiol Lung Cell Mol Physiol (2009) 0.82
The MHC class I genes of zebrafish. Dev Comp Immunol (2014) 0.81
HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation. PLoS One (2012) 0.81
The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J Mol Biol (2010) 0.81
MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection. J Immunol (2012) 0.80
Evolution of nonclassical MHC-dependent invariant T cells. Cell Mol Life Sci (2014) 0.80
Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome. Front Immunol (2015) 0.80
At least one YMHCI molecule in the chicken is alloimmunogenic and dynamically expressed on spleen cells during development. Immunogenetics (2006) 0.80
Natural selection on marine carnivores elaborated a diverse family of classical MHC class I genes exhibiting haplotypic gene content variation and allelic polymorphism. Immunogenetics (2012) 0.80
Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients. PLoS One (2012) 0.80
Species-specific evolution of class I MHC genes in iguanas (order: Squamata; subfamily: Iguaninae). Immunogenetics (2008) 0.80
Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity. J Immunol (2014) 0.80
Restricting nonclassical MHC genes coevolve with TRAV genes used by innate-like T cells in mammals. Proc Natl Acad Sci U S A (2016) 0.79
Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS One (2007) 0.79
Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity. Mol Cells (2013) 0.79
Characteristics of MHC class I genes in house sparrows Passer domesticus as revealed by long cDNA transcripts and amplicon sequencing. J Mol Evol (2013) 0.78
Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide. Immunogenetics (2010) 0.78
An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus. J Immunol (2011) 0.78
SAP is required for the development of innate phenotype in H2-M3--restricted Cd8(+) T cells. J Immunol (2012) 0.78
Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection. PLoS Pathog (2016) 0.77
Increased HLA-E expression in white matter lesions in multiple sclerosis. Immunology (2012) 0.77
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia. Oncoimmunology (2016) 0.77
Evolution of MHC class I genes in the European badger (Meles meles). Ecol Evol (2012) 0.77
Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice. Front Immunol (2017) 0.76
Comeback kids: CD8(+) suppressor T cells are back in the game. J Clin Invest (2010) 0.76
A nonclassical MHC class I U lineage locus in zebrafish with a null haplotypic variant. Immunogenetics (2015) 0.76
Mechanisms and Consequences of Antigen Presentation by CD1. Trends Immunol (2016) 0.75
Structure and function of the non-classical major histocompatibility complex molecule MR1. Immunogenetics (2016) 0.75
Don't mess with ERAAP! Nat Immunol (2012) 0.75
Targeting Innate-Like T Cells in Tuberculosis. Front Immunol (2016) 0.75
Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine (2016) 0.75
Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs. Immunogenetics (2015) 0.75
Selective dependence of H2-M3-restricted CD8 responses on IL-15. J Immunol (2012) 0.75
Antigen Processing in the Endoplasmic Reticulum Is Monitored by Semi-Invariant αβ TCRs Specific for a Conserved Peptide-Qa-1b MHC Class Ib Ligand. J Immunol (2017) 0.75
Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K. Immunogenetics (2013) 0.75
The role of MHC class Ib-restricted T cells during infection. Immunogenetics (2016) 0.75
Tumor immunology viewed from alternative animal models-the Xenopus story. Curr Pathobiol Rep (2017) 0.75
Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide. PLoS One (2017) 0.75
Immunotherapy with Listeria reduces metastatic breast cancer in young and old mice through different mechanisms. Oncoimmunology (2017) 0.75
Human PAD4 regulates histone arginine methylation levels via demethylimination. Science (2004) 5.46
Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression. Mol Cell Biol (2002) 5.42
Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell (2008) 3.09
Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites. J Biol Chem (2003) 2.04
The novel SLIK histone acetyltransferase complex functions in the yeast retrograde response pathway. Mol Cell Biol (2002) 1.98
Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res (2003) 1.73
A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment. J Biol Chem (2006) 1.46
Modifications of H3 and H4 during chromatin replication, nucleosome assembly, and histone exchange. J Biol Chem (2006) 1.42
ABRF-2002ESRG, a difficult sequence: Analysis of a PVDF-bound known protein with a heterogeneous amino-terminus. J Biomol Tech (2002) 1.41
Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motif. J Biol Chem (2004) 1.28
Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol (2006) 1.27
Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers. Gene (2009) 1.05
ABRF-ESRG'03: analysis of a PVDF-bound known protein with a homogeneous amino-terminus. J Biomol Tech (2003) 0.98
Characterization and serologic analysis of the Treponema pallidum proteome. Infect Immun (2010) 0.90
Hyperconservation of the N-formyl peptide binding site of M3: evidence that M3 is an old eutherian molecule with conserved recognition of a pathogen-associated molecular pattern. J Immunol (2003) 0.84
Hyperconservation of the putative antigen recognition site of the MHC class I-b molecule TL in the subfamily Murinae: evidence that thymus leukemia antigen is an ancient mammalian gene. J Immunol (2002) 0.81
Identification of phosphorylation sites by Edman degradation. Methods Mol Biol (2003) 0.75
Clostridium difficile lacks detectable superantigen activity. FEMS Immunol Med Microbiol (2006) 0.75